Peer-reviewedLicence not statedMolecular Pharmacology
Panoramic characterization of proposed ligands for GPR3: oleoylethanolamide as a pharmacological chaperone
- 1Biochemistry, Cell, & Developmental Biology Graduate Program, Emory University, Atlanta, Georgia
- 2Department of Pharmacology & Chemical Biology, Emory University School of Medicine, Atlanta, Georgia
- 3Molecular & Systems Pharmacology Graduate Program, Emory University, Atlanta, Georgia
Related
- Functional characterization of terpene synthases from Dendrobium nobile provides insights into the biosynthesis of copaborneol, a proposed dendrobine precursor
- The cysteine-rich domain of SEP15, a selenoprotein co-chaperone of the ER chaperone, UDP-glucose:glycoprotein glucosyltransferase, adopts a novel fold
- Opposing Regulation of Tau Condensation by Phosphorylation Levels and Molecular Chaperone Interactions
- A protease-resistant D-amino acid αA-crystallin mini-chaperone with enhanced chaperone and antioxidant activities protects against amyloid-β proteotoxicity
- Pathogenic Variants in the Myosin Chaperone UNC-45B Cause Progressive Myopathy with Eccentric Cores
BibTeX
@article{pyne2026panoramic,
title = {{Panoramic characterization of proposed ligands for GPR3: oleoylethanolamide as a pharmacological chaperone}},
author = {Ian T. Pyne and Alex J. Roy and Sophia Boraschi and Sanjit S. Hajgude and Randy A. Hall},
journal = {Molecular Pharmacology},
year = {2026},
month = jul,
doi = {10.1016/j.molpha.2026.100146},
url = {https://doi.org/10.1016/j.molpha.2026.100146},
}
RIS
TY - JOUR
TI - Panoramic characterization of proposed ligands for GPR3: oleoylethanolamide as a pharmacological chaperone
AU - Ian T. Pyne
AU - Alex J. Roy
AU - Sophia Boraschi
AU - Sanjit S. Hajgude
AU - Randy A. Hall
PY - 2026
DA - 2026/07/24
JO - Molecular Pharmacology
DO - 10.1016/j.molpha.2026.100146
UR - https://doi.org/10.1016/j.molpha.2026.100146
SN - 0026-895X
SN - 1521-0111
ER -